期刊
出版社
NATL ACAD SCIENCES
DOI: 10.1073/pnas.2103319118
关键词
apoptosis; netrin-1; p53 isoform
资金
- CNRS
- INSERM
- University of Lyon
- Centre Leon Berard
- Ligue Contre le Cancer
- Institut National du Cancer
- Agence Nationale de Recherches
- European Research Council
- Fondation Bettencourt
- China Scholarship Council
- Nuovo-Soldati Cancer Research Foundation
Netrin-1, a secreted protein known as a relevant cancer therapeutic target, promotes cancer progression by inhibiting cell death induced by its receptors. The study shows that p53 positively regulates Netrin-1 gene expression, and the A40p53 isoform can activate the Netrin-1 promoter to promote cell survival.
Netrin-1, a secreted protein recently characterized as a relevant cancer therapeutic target, is the antiapoptotic ligand of the dependence receptors deleted in colorectal carcinoma and members of the UNC5H family. Netrin-1 is overexpressed in several aggressive cancers where it promotes cancer progression by inhibiting cell death induced by its receptors. Interference of its binding to its receptors has been shown, through the development of a monoclonal neutralizing antinetrin-1 antibody (currently in phase II of clinical trial), to actively induce apoptosis and tumor growth inhibition. The transcription factor p53 was shown to positively regulate netrin-1 gene expression. We show here that netrin-1 could be a target gene of the N-terminal p53 isoform A40p53, independent of full-length p53 activity. Using stable cell lines, harboring wild-type or null-p53, in which A40p53 expression could be finely tuned, we prove that A40p53 binds to and activates the netrin-1 promoter. In addition, we show that forcing immortalized human skeletal myoblasts to produce the A40p53 isoform, instead of full-length p53, leads to the up-regulation of netrin-1 and its receptor UNC5B and promotes cell survival. Indeed, we demonstrate that netrin-1 interference, in the presence of A40p53, triggers apoptosis in cancer and primary cells, leading to tumor growth inhibition in preclinical in vivo models. Finally, we show a positive correlation between netrin-1 and A40p53 gene expression in human melanoma and colorectal cancer biopsies. Hence, we propose that inhibition of netrin1 binding to its receptors should be a promising therapeutic strategy in human tumors expressing high levels of A40p53.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据